Suivre
Zoltan Mari
Zoltan Mari
Adresse e-mail validée de ccf.org - Page d'accueil
Titre
Citée par
Citée par
Année
Identifying true brain interaction from EEG data using the imaginary part of coherency
G Nolte, O Bai, L Wheaton, Z Mari, S Vorbach, M Hallett
Clinical neurophysiology 115 (10), 2292-2307, 2004
18822004
The Parkinson progression marker initiative (PPMI)
K Marek, D Jennings, S Lasch, A Siderowf, C Tanner, T Simuni, C Coffey, ...
Progress in neurobiology 95 (4), 629-635, 2011
15272011
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
SP Yun, TI Kam, N Panicker, SM Kim, Y Oh, JS Park, SH Kwon, YJ Park, ...
Nature medicine 24 (7), 931-938, 2018
8732018
Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease
JH Kang, DJ Irwin, AS Chen-Plotkin, A Siderowf, C Caspell, CS Coffey, ...
JAMA neurology 70 (10), 1277-1287, 2013
4232013
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit
MF Beal, D Oakes, I Shoulson, C Henchcliffe, WR Galpern, R Haas, ...
JAMA neurology 71 (5), 543-552, 2014
2982014
Tourette syndrome deep brain stimulation: a review and updated recommendations
LE Schrock, JW Mink, DW Woods, M Porta, D Servello, ...
Movement disorders 30 (4), 448-471, 2015
2612015
Efficacy and safety of deep brain stimulation in Tourette syndrome: the international Tourette syndrome deep brain stimulation public database and registry
D Martinez-Ramirez, J Jimenez-Shahed, JF Leckman, M Porta, D Servello, ...
JAMA neurology 75 (3), 353-359, 2018
2242018
National randomized controlled trial of virtual house calls for Parkinson disease
CA Beck, DB Beran, KM Biglan, CM Boyd, ER Dorsey, PN Schmidt, ...
Neurology 89 (11), 1152-1161, 2017
2102017
Scientific and ethical issues related to deep brain stimulation for disorders of mood, behavior, and thought
P Rabins, BS Appleby, J Brandt, MR DeLong, LB Dunn, L Gabriëls, ...
Archives of general psychiatry 66 (9), 931-937, 2009
2062009
Widespread abnormality of the γ-aminobutyric acid-ergic system in Tourette syndrome
A Lerner, A Bagic, JM Simmons, Z Mari, O Bonne, B Xu, D Kazuba, ...
Brain 135 (6), 1926-1936, 2012
1942012
The past, present, and future of telemedicine for Parkinson's disease
M Achey, JL Aldred, N Aljehani, BR Bloem, KM Biglan, P Chan, E Cubo, ...
Movement disorders 29 (7), 871-883, 2014
1882014
Asymmetric spatiotemporal patterns of event-related desynchronization preceding voluntary sequential finger movements: a high-resolution EEG study
O Bai, Z Mari, S Vorbach, M Hallett
Clinical neurophysiology 116 (5), 1213-1221, 2005
1852005
Diffusion, spread, and migration of botulinum toxin
J Ramirez‐Castaneda, J Jankovic, C Comella, K Dashtipour, ...
Movement disorders 28 (13), 1775-1783, 2013
1792013
Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial
K Kieburtz, BC Tilley, JJ Elm, D Babcock, R Hauser, GW Ross, ...
Jama 313 (6), 584-593, 2015
1732015
Neuroimaging of neuronal circuits involved in tic generation in patients with Tourette syndrome
A Lerner, A Bagic, EA Boudreau, T Hanakawa, F Pagan, Z Mari, ...
Neurology 68 (23), 1979-1987, 2007
1262007
Involvement of insula and cingulate cortices in control and suppression of natural urges
A Lerner, A Bagic, T Hanakawa, EA Boudreau, F Pagan, Z Mari, ...
Cerebral cortex 19 (1), 218-223, 2009
1212009
Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls
B Mollenhauer, CJ Caspell-Garcia, CS Coffey, P Taylor, LM Shaw, ...
Neurology 89 (19), 1959-1969, 2017
1152017
Continuous assessment of levodopa response in Parkinson's disease using wearable motion sensors
CL Pulliam, DA Heldman, EB Brokaw, TO Mera, ZK Mari, MA Burack
IEEE Transactions on Biomedical Engineering 65 (1), 159-164, 2017
1112017
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial
GU Höglinger, I Litvan, N Mendonca, D Wang, H Zheng, ...
The Lancet Neurology 20 (3), 182-192, 2021
1062021
Efficacy of nilotinib in patients with moderately advanced Parkinson disease: a randomized clinical trial
T Simuni, B Fiske, K Merchant, CS Coffey, E Klingner, C Caspell-Garcia, ...
JAMA neurology 78 (3), 312-320, 2021
982021
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20